药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etidronic acid
Trilostane
The risk or severity of edema formation can be increased when Trilostane is combined with Aldosterone.
Etidronic acid
Phenylacetic acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Aldosterone.
Etidronic acid
Glycerol phenylbutyrate
The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Aldosterone.
Etidronic acid
Phenylbutyric acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Aldosterone.
Etidronic acid
Alcuronium
The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Aldosterone.
Etidronic acid
Gallamine
The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Aldosterone.
Etidronic acid
Atracurium
The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Aldosterone.
Etidronic acid
Neosaxitoxin
The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Aldosterone.
Etidronic acid
Pyrantel
The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Aldosterone.
Etidronic acid
Rapacuronium
The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Aldosterone.
Etidronic acid
Metocurine
The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Aldosterone.
Etidronic acid
Mivacurium
The risk or severity of myopathy and weakness can be increased when Mivacurium is combined with Aldosterone.
Etidronic acid
Doxacurium
The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Aldosterone.
Etidronic acid
Neostigmine
The therapeutic efficacy of Neostigmine can be decreased when used in combination with Aldosterone.
Etidronic acid
Capsaicin
The therapeutic efficacy of Capsaicin can be decreased when used in combination with Aldosterone.
Etidronic acid
Ketamine
The therapeutic efficacy of Ketamine can be decreased when used in combination with Aldosterone.
Etidronic acid
Methylphosphinic Acid
The therapeutic efficacy of Methylphosphinic Acid can be decreased when used in combination with Aldosterone.
Etidronic acid
Pipecuronium
The therapeutic efficacy of Aldosterone can be decreased when used in combination with Pipecuronium.
Etidronic acid
Decamethonium
The therapeutic efficacy of Aldosterone can be decreased when used in combination with Decamethonium.
Etidronic acid
Posiphen
The therapeutic efficacy of Posiphen can be decreased when used in combination with Aldosterone.